A Clinical Trial of MK-1406 in Healthy Participants (MK-1406-008)
NCT07743151
This study is recruiting at 4 US sites in 3 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this trial is to compare what happens to MK-1406 in the body of healthy participants when it is given as 2-injections and 3-injections. Researchers also want to learn about the safety of MK-1406 and if people tolerate it.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Healthy
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 to 64 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Merck Sharp & Dohme LLC
- Last updated on ClinicalTrials.gov
- October 5, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Florida · 2
- Research Centers of America ( Hollywood ) ( Site 0008) · Hollywood, FL
- QPS-MRA, LLC ( Site 0007) · South Miami, FL
New Jersey · 1
- Hassman Research Institute Marlton Site ( Site 0001) · Marlton, NJ
Ohio · 1
- Velocity Clinical Research, Cleveland ( Site 0005) · Cleveland, OH
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.